Press Resease

Prostate Cancer Therapeutics Market: By Therapy (Hormone Therapy, Targeted Therapy, Chemotherapy, and Biologic Therapy) and By Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 23-Jan-2020 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2320 Status : Published

According to the report, global demand for the Prostate Cancer Therapeutics Market was valued at nearly USD 9,801.69 Million in 2019 and is expected to generate revenue of around USD 16,557.08 Million by end of 2026, growing at a CAGR of over 7.82 % between 2020 and 2026.

Description

The report comprises of revenue projection & study of the Prostate Cancer Therapeutics market on a global as well as regional level.  It also offers historical data from 2016 to 2019 and provides an industry overview during 2020-2026 in terms of USD Million. Our report includes competitive strategies enforced by the key industry players based on Porter’s Five Forces Model impacting the industry as well as competition.

According to the report, global demand for the Prostate Cancer Therapeutics Market was valued at nearly USD 9,801.69 Million in 2019 and is expected to generate revenue of around USD 16,557.08 Million by end of 2026, growing at a CAGR of over 7.82 % between 2020 and 2026.

Our study offers precise market attractiveness analysis, thereby succoring the buyer in exploring the huge growth aspects of the Prostate Cancer Therapeutics market over the timespan from 2020 to 2026. The report also provides data about the market from 2016 to 2019. Moreover, the market is segmented into therapy, distribution channel, and region.

Global Prostate Cancer Therapeutics Market

Based on the therapy, the prostate cancer therapeutics industry is classified into Hormone Therapy, Targeted Therapy, Chemotherapy, and Biologic Therapy. In terms of distribution channel, the market is divided into Hospital Pharmacies, Online Sales, Retail Pharmacies, and Others. Region-wise, the prostate cancer therapeutics market is segregated into North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The report includes an in-depth PESTEL and SWOT Analysis that examines the myriad factors influencing the performance of each market player in the present situation and over the forecast period. It also offers comprehensive insights into the competitive moves made by the mammoth industry players for acquiring a leading position in the market by raising their market share.

Key Drivers:

The introduction of new medicines, drug combinations, and drug sequences are expected to bring improvements in the treatment of prostate cancer. Additionally, the growing significance of DNA damage repair metamorphoses in the patients affected due to prostate cancer will offer new growth avenues for the market over the forecast period. Firms are adopting strategies like drug repositioning for effectively treating prostate cancer without hazardous effects on the subjects/patients. This will create lucrative avenues for the market over the forecast period.

The key players leveraging prostate cancer therapeutics market evolution and included in the report are:

  • Bayer AG
  • Johnson & Johnson
  • Ipsen Group
  • Amgen, Inc.
  • Endo Pharmaceuticals, Inc.
  • AbbVie, Inc.
  • Pfizer, Inc.
  • AstraZeneca
  • Sanofi
  • Sanpower Group

This report segments the Prostate Cancer Therapeutics market as follows:

Global Prostate Cancer Therapeutics Market: By Therapy Segment Analysis

  • Hormone Therapy

  • Targeted Therapy

  • Chemotherapy

  • Biologic Therapy

Global Prostate Cancer Therapeutics Market: By Distribution Channel Segment Analysis

  • Hospital Pharmacies

  • Online Sales

  • Retail Pharmacies

  • Others

Global Prostate Cancer Therapeutics Market: By Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Executive Summary 19
  • Chapter 2. Prostate Cancer Therapeutics market - Therapy Analysis 21
    • 2.1. Global Prostate Cancer Therapeutics Market - Therapy Overview 21
    • 2.2. Global Prostate Cancer Therapeutics Market Share, by Therapy, 2019 & 2026 (USD Million ) 21
    • 2.3. Hormone Therapy 23
      • 2.3.1. Global Hormone Therapy Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 23
    • 2.4. Targeted Therapy 24
      • 2.4.1. Global Targeted Therapy Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 24
    • 2.5. Chemotherapy 25
      • 2.5.1. Global Chemotherapy Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 25
    • 2.6. Biologic Therapy 26
      • 2.6.1. Global Biologic Therapy Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 26
  • Chapter 3. Prostate Cancer Therapeutics market - Distribution Channel Analysis 26
    • 3.1. Global Prostate Cancer Therapeutics Market - Distribution Channel Overview 26
    • 3.2. Global Prostate Cancer Therapeutics Market Share, by Distribution Channel, 2019 & 2026 (USD Million ) 27
    • 3.3. Hospital Pharmacies 28
      • 3.3.1. Global Hospital Pharmacies Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 28
    • 3.4. Online Sales 29
      • 3.4.1. Global Online Sales Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 29
    • 3.5. Retail Pharmacies 30
      • 3.5.1. Global Retail Pharmacies Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 30
    • 3.6. Others 31
      • 3.6.1. Global Others Prostate Cancer Therapeutics Market, 2020-2026 (USD Million ) 31
  • Chapter 4. Prostate Cancer Therapeutics market - Regional Analysis 32
    • 4.1. Global Prostate Cancer Therapeutics Market Regional Overview 32
    • 4.2. Global Prostate Cancer Therapeutics Market Share, by Region, 2019 & 2026 (Value) 32
    • 4.3. North America 34
      • 4.3.1. North America Prostate Cancer Therapeutics Market size and forecast, 2020-2026 34
      • 4.3.2. North America Prostate Cancer Therapeutics Market, by Country, 2019 & 2026 (USD Million ) 34
      • 4.3.3. North America Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 36
        • 4.3.3.1. North America Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 (USD Million ) 36
      • 4.3.4. North America Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 37
        • 4.3.4.1. North America Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 (USD Million ) 37
      • 4.3.5. U.S. 38
        • 4.3.5.1. U.S. Market size and forecast, 2020-2026 (USD Million ) 38
      • 4.3.6. Canada 39
        • 4.3.6.1. Canada Market size and forecast, 2020-2026 (USD Million ) 39
    • 4.4. Europe 40
      • 4.4.1. Europe Prostate Cancer Therapeutics Market size and forecast, 2020-2026 40
      • 4.4.2. Europe Prostate Cancer Therapeutics Market, by Country, 2019 & 2026 (USD Million ) 40
      • 4.4.3. Europe Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 42
        • 4.4.3.1. Europe Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 (USD Million ) 42
      • 4.4.4. Europe Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 43
        • 4.4.4.1. Europe Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 (USD Million ) 43
      • 4.4.5. Germany 44
        • 4.4.5.1. Germany Market size and forecast, 2020-2026 (USD Million ) 44
      • 4.4.6. France 45
        • 4.4.6.1. France Market size and forecast, 2020-2026 (USD Million ) 45
      • 4.4.7. U.K. 46
        • 4.4.7.1. U.K. Market size and forecast, 2020-2026 (USD Million ) 46
      • 4.4.8. Italy 47
        • 4.4.8.1. Italy Market size and forecast, 2020-2026 (USD Million ) 47
      • 4.4.9. Spain 48
        • 4.4.9.1. Spain Market size and forecast, 2020-2026 (USD Million ) 48
      • 4.4.10. Rest of Europe 49
        • 4.4.10.1. Rest of Europe Market size and forecast, 2020-2026 (USD Million ) 49
    • 4.5. Asia Pacific 50
      • 4.5.1. Asia Pacific Prostate Cancer Therapeutics Market size and forecast, 2020-2026 50
      • 4.5.2. Asia Pacific Prostate Cancer Therapeutics Market, by Country, 2019 & 2026 (USD Million ) 50
      • 4.5.3. Asia Pacific Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 52
        • 4.5.3.1. Asia Pacific Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 (USD Million ) 52
      • 4.5.4. Asia Pacific Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 53
      • 4.5.4.1. Asia Pacific Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 (USD Million ) 53
      • 4.5.5. China 54
        • 4.5.5.1. China Market size and forecast, 2020-2026 (USD Million ) 54
      • 4.5.6. Japan 55
        • 4.5.6.1. Japan Market size and forecast, 2020-2026 (USD Million ) 55
      • 4.5.7. India 56
        • 4.5.7.1. India Market size and forecast, 2020-2026 (USD Million ) 56
      • 4.5.8. South Korea 57
        • 4.5.8.1. South Korea Market size and forecast, 2020-2026 (USD Million ) 57
      • 4.5.9. South-East Asia 58
        • 4.5.9.1. South-East Asia Market size and forecast, 2020-2026 (USD Million ) 58
      • 4.5.10. Rest of Asia Pacific 59
        • 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2020-2026 (USD Million ) 59
    • 4.6. Latin America 60
      • 4.6.1. Latin America Prostate Cancer Therapeutics Market size and forecast, 2020-2026 60
      • 4.6.2. Latin America Prostate Cancer Therapeutics Market, by Country, 2019 & 2026 (USD Million ) 60
      • 4.6.3. Latin America Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 62
        • 4.6.3.1. Latin America Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 (USD Million ) 62
      • 4.6.4. Latin America Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 63
        • 4.6.4.1. Latin America Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 (USD Million ) 63
      • 4.6.5. Brazil 64
        • 4.6.5.1. Brazil Market size and forecast, 2020-2026 (USD Million ) 64
      • 4.6.6. Mexico 65
        • 4.6.6.1. Mexico Market size and forecast, 2020-2026 (USD Million ) 65
      • 4.6.7. Rest of Latin America 66
        • 4.6.7.1. Rest of Latin America Market size and forecast, 2020-2026 (USD Million ) 66
    • 4.7. The Middle-East and Africa 67
      • 4.7.1. The Middle-East and Africa Prostate Cancer Therapeutics Market size and forecast, 2020-2026 67
      • 4.7.2. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Country, 2019 & 2026 (USD Million ) 67
      • 4.7.3. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 69
        • 4.7.3.1. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Therapy, 2020-2026 (USD Million ) 69
      • 4.7.4. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 70
        • 4.7.4.1. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Distribution Channel, 2020-2026 (USD Million ) 70
      • 4.7.5. GCC Countries 71
        • 4.7.5.1. GCC Countries Market size and forecast, 2020-2026 (USD Million ) 71
      • 4.7.6. South Africa 72
        • 4.7.6.1. South Africa Market size and forecast, 2020-2026 (USD Million ) 72
      • 4.7.7. Rest of Middle-East Africa 73
        • 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2020-2026 (USD Million ) 73
  • Chapter 5. Prostate Cancer Therapeutics market - Competitive Landscape 74
    • 5.1. Competitor Market Share - Revenue 74
    • 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 76
    • 5.3. Strategic Development 77
      • 5.3.1. Acquisitions and Mergers 77
      • 5.3.2. New Products 77
      • 5.3.3. Research & Development Activities 77
  • Chapter 6. Company Profiles 78
    • 6.1. Bayer AG 78
      • 6.1.1. Company Overview 78
      • 6.1.2. Bayer AG Revenue and Gross Margin 78
      • 6.1.3. Product portfolio 79
      • 6.1.4. Recent initiatives 80
    • 6.2. Johnson & Johnson 80
      • 6.2.1. Company Overview 80
      • 6.2.2. Johnson & Johnson Revenue and Gross Margin 80
      • 6.2.3. Product portfolio 81
      • 6.2.4. Recent initiatives 82
    • 6.3. Ipsen Group 82
      • 6.3.1. Company Overview 82
      • 6.3.2. Ipsen Group Revenue and Gross Margin 82
      • 6.3.3. Product portfolio 83
      • 6.3.4. Recent initiatives 84
    • 6.4. Amgen Inc. 84
      • 6.4.1. Company Overview 84
      • 6.4.2. Amgen Inc. Revenue and Gross Margin 84
      • 6.4.3. Product portfolio 85
      • 6.4.4. Recent initiatives 86
    • 6.5. Endo Pharmaceuticals Inc. 86
      • 6.5.1. Company Overview 86
      • 6.5.2. Endo Pharmaceuticals Inc. Revenue and Gross Margin 86
      • 6.5.3. Product portfolio 87
      • 6.5.4. Recent initiatives 88
    • 6.6. AbbVie Inc. 88
      • 6.6.1. Company Overview 88
      • 6.6.2. AbbVie Inc. Revenue and Gross Margin 88
      • 6.6.3. Product portfolio 89
      • 6.6.4. Recent initiatives 90
    • 6.7. Pfizer Inc. 90
      • 6.7.1. Company Overview 90
      • 6.7.2. Pfizer Inc. Revenue and Gross Margin 90
      • 6.7.3. Product portfolio 91
      • 6.7.4. Recent initiatives 92
    • 6.8. AstraZeneca 92
      • 6.8.1. Company Overview 92
      • 6.8.2. AstraZeneca Revenue and Gross Margin 92
      • 6.8.3. Product portfolio 93
      • 6.8.4. Recent initiatives 94
    • 6.9. Sanofi 94
      • 6.9.1. Company Overview 94
      • 6.9.2. Sanofi Revenue and Gross Margin 94
      • 6.9.3. Product portfolio 95
      • 6.9.4. Recent initiatives 96
    • 6.10. Sanpower Group 96
      • 6.10.1. Company Overview 96
      • 6.10.2. Sanpower Group Revenue and Gross Margin 96
      • 6.10.3. Product portfolio 97
      • 6.10.4. Recent initiatives 98
  • Chapter 7. Prostate Cancer Therapeutics — Industry Analysis 99
    • 7.1. Prostate Cancer Therapeutics Market - Key Trends 99
      • 7.1.1. Market Drivers 100
      • 7.1.2. Market Restraints 100
      • 7.1.3. Market Opportunities 101
    • 7.2. Value Chain Analysis 102
    • 7.3. Technology Roadmap and Timeline 103
    • 7.4. Prostate Cancer Therapeutics Market - Attractiveness Analysis 104
      • 7.4.1. By Therapy 104
      • 7.4.2. By Distribution Channel 104
      • 7.4.3. By Region 106
  • Chapter 8. Marketing Strategy Analysis, Distributors 107
    • 8.1. Marketing Channel 107
    • 8.2. Direct Marketing 108
    • 8.3. Indirect Marketing 108
    • 8.4. Marketing Channel Development Trend 108
    • 8.5. Economic/Political Environmental Change 109
  • Chapter 9. Report Conclusion 110
  • Chapter 10. Research Approach & Methodology 111
    • 10.1. Report Description 111
    • 10.2. Research Scope 112
    • 10.3. Research Methodology 112
      • 10.3.1. Secondary Research 113
      • 10.3.2. Primary Research 114
      • 10.3.3. Models 115
        • 10.3.3.1. Company Share Analysis Model 115
        • 10.3.3.2. Revenue Based Modeling 116
        • 10.3.3.3. Research Limitations 116

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com